-
SPRY Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
ARS Pharmaceuticals (SPRY)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 39.66 mm | 39.66 mm | 39.66 mm | 39.66 mm | 39.66 mm | 39.66 mm |
Cash burn (monthly) | (no burn) | 1.74 mm | 7.25 mm | 5.04 mm | 4.82 mm | 3.82 mm |
Cash used (since last report) | n/a | 7.89 mm | 32.86 mm | 22.86 mm | 21.86 mm | 17.32 mm |
Cash remaining | n/a | 31.77 mm | 6.79 mm | 16.80 mm | 17.80 mm | 22.33 mm |
Runway (months of cash) | n/a | 18.3 | 0.9 | 3.3 | 3.7 | 5.8 |
13F holders | Current |
---|---|
Total holders | 153 |
Opened positions | 46 |
Closed positions | 13 |
Increased positions | 57 |
Reduced positions | 23 |
13F shares | Current |
---|---|
Total value | 906.00 bn |
Total shares | 82.20 mm |
Total puts | 589.40 k |
Total calls | 871.80 k |
Total put/call ratio | 0.7 |
Largest owners | Shares | Value |
---|---|---|
Deerfield Management | 11.08 mm | $160.63 bn |
Flynn James E | 11.08 mm | $0.00 |
Ra Capital Management | 10.86 mm | $157.48 bn |
Orbimed Advisors | 8.29 mm | $120.18 bn |
Pratik Shah Living Trust dated June 15, 2011 | 5.22 mm | $46.66 mm |
BlackRock | 4.25 mm | $61.57 bn |
SR One Capital Management | 4.01 mm | $58.19 bn |
Vanguard | 3.35 mm | $48.56 bn |
BEN Franklin Resources | 2.84 mm | $42.42 bn |
STT State Street | 2.05 mm | $29.72 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
3 Feb 25 | Shawver Laura | Common Stock | Sell | Dispose S | No | Yes | 12.3113 | 50,000 | 615.57 k | 210,346 |
3 Feb 25 | Shawver Laura | Common Stock | Option exercise | Acquire M | No | No | 4.85 | 40,936 | 198.54 k | 260,346 |
3 Feb 25 | Shawver Laura | Common Stock | Option exercise | Acquire M | No | No | 3.15 | 9,064 | 28.55 k | 219,410 |
3 Feb 25 | Shawver Laura | Stock Option Common Stock | Option exercise | Dispose M | No | No | 4.85 | 40,936 | 198.54 k | 124,064 |
3 Feb 25 | Shawver Laura | Stock Option Common Stock | Option exercise | Dispose M | No | No | 3.15 | 9,064 | 28.55 k | 0 |
6 Jan 25 | Shawver Laura | Common Stock | Sell | Dispose S | No | Yes | 11.1013 | 50,000 | 555.07 k | 210,346 |
6 Jan 25 | Shawver Laura | Common Stock | Option exercise | Acquire M | No | No | 3.15 | 50,000 | 157.50 k | 260,346 |
6 Jan 25 | Shawver Laura | Stock Option Common Stock | Option exercise | Dispose M | No | No | 3.15 | 50,000 | 157.50 k | 9,064 |
2 Jan 25 | Sarina Tanimoto | Stock Option Common Stock | Grant | Acquire A | Yes | No | 10.71 | 767,600 | 8.22 mm | 767,600 |
2 Jan 25 | Sarina Tanimoto | Stock option Common Stock | Grant | Acquire A | No | No | 10.71 | 261,900 | 2.80 mm | 261,900 |